In the blog I wrote in June 2012 I discussed the proposed physician payment Sunshine Act in the USA. This has now come into effect as of August 1st 2013 and it will be interesting to see what impact this has on physician payments and this rather hidden interaction between industry and medical practitioners. As noted […]
This is a very interesting study in which 500 board certified internists were presented with abstracts that described a clinical trial of three hypothetical drugs. The trials had a high, a medium or a low level of quality and each report had included a disclosure about the source of funding, either from a pharmaceutical company, […]
We have all been accustomed in the past to receiving lecture fees, assistance with travel to conferences and even dinners provided by the pharmaceutical industry. However this type of subsidy of doctors’ activities is decreasing and is going to be far more transparent than hitherto. Andrew Jack, the pharmaceutical correspondent for the Financial Times, states […]